Progress-PME highlights CMC expertise at HollandBIO 2019

news-releasesProgress Project Management & Engineering (Progress-PME)

June 14th 2019

Hoofddorp, The Netherlands: – Progress Project Management & Engineering (Progress-PME), the independent consultancy and management company specializing in the pharmaceutical, biotech and healthcare industries, will be a prominent presence at this June’s Dutch Biotech Event, HollandBIO 2019, at Maarssen, near Utrecht in The Netherlands.

A joined Progress-PME and Progress-EXS team consisting of Chief Commercial Officer Edwin van den Bos Alwin Voetman, Sales Director of its high-level strategic consultancy arm Progress EXS and Thijs Veerman, COO of Progress-EXS, will use the conference and networking event to present the company’s broad range of operational and strategic management services.

CMC service offerings

Progress-PME, currently celebrating its 20^th Anniversary, will share insights on its expert services for biotech companies that include project management, chemistry, manufacturing and controls (CMC) development, CMC regulatory support, QA/QC/QP services, Engineering and Lean Six Sigma performance improvement

“CMC is a key area for biotech and at the heart of many of the aspects that will be discussed at HollandBIO,” noted Edwin van den Bos.

To the top, together

The company will also be talking about its expertise in quality management and regulatory advise for biotech products and ATMPs Progress-PME consultants are currently supporting prominent client Kite Pharma EU, within its QA and QC departments with setting up and further improving its quality systems. Kite, a Gilead company, has been at the forefront of cancer immunotherapy and is currently a leader in engineered T cell therapy.

“With core expertise in these and so many other fields crucial to biotech innovation and success , we expect to have many interesting and valuable conversations in Maarssen,” said Mr. Van den Bos.

“We will be reaching out to the many biotech players of all shapes and sizes gathered there to explore ways in which we can follow our corporate strapline, ’To the top, together’ he added.

About Progress-PME

Progress-PME is an independent consultancy company with customers in the pharmaceutical and biotechnology industries and in the healthcare sector. It operates internationally, supplying project management, engineering, CMC, validation Lean/OPex and quality assurance services.

Progress-PME’s mission is to excel in supporting clients to realize their business goals, harnessing broad knowledge and experience, combined with focus and flexibility to guarantee high value services and projects and multi-disciplinary progress. Progress-PME offers general services in eight fields: project management, a specialized Quick scan & GAP analysis services helping companies into new markets or products, training, hospital pharmacy support, biobanking, and environmental management.

The company also offers management services covering fields such as Quality Management, Lean Six Sigma performance improvement, Chemistry Manufacturing and Control (CMC) for new pharmaceutical products, engineering and facilities support.

Founded in 1999, Progress-PME and its Executive Services subsidiary Progress EXS are privately-owned companies.

Further information at: https://www.progress-pme.com/home.html

About HollandBIO 2019

The annual Dutch Biotech Event (HollandBIO) is a conference that welcomes biotech companies of all shapes and sizes, from start-ups to established multinationals, with a focus on emerging trends and innovative technologies.

The event offers keynote addresses from leading biotech entrepreneurs, hands-on technology workshops and networking with industry leaders and experts.

HollandBIO 2019 is a one-day event held June 28 at the InnStyle hotel in Maarssen.

The 2019 conference will feature keynote presentations from Kite Pharma founder, Dr. Arie Belldegrun, Executive Chairman and Co-Founder of Allogene and Chairman of Two River Group, UroGen Pharma and Kronos Bio, as well as from Dr. John Haurum, former CEO of F-Star Biotechnology and currently Chairman of Belgium’s AgomAb Therapeutics, whose CEO, Tim Knotnerus, will also address the conference.

The event is organized by HollandBIO with further information at: https://www.hollandbio.nl/event/dutch-biotech-event-2/